Abstract:OBJECTIVE:To explore the value of diffusion weighted imaging (DWI) and perfusion weighted imaging (PWI) in identifying benign and malignant renal masses and differentiating the histological types of renal masses. METHODS:Fifteen healthy volunteers and 46 patients with renal masses proven by pathology, including clear cell carcinomas (n = 18), papillary carcinomas (n = 8), chromophobe carcinomas (n = 7) and angiomyolipomas (n = 13), were examined with DWI and PWI scan at 3.0 T MRI. ANOVA was employed to compare the values of transfer constant (K(trans)), rate constant of backflux (Kep) and extra-vascular extra-cellular space fractional volume (Ve) proceeded by PWI and the value of ADC resulted from DWI between normal kidney and different histological types of renal masses. Receiver operating characteristics (ROC) curve was used to analyze and compare the diagnostic value of the methods of PWI and DWI in differentiating benign and malignant renal masses. RESULTS:The ADC value of normal renal parenchyma was (2.10 ± 0.24) × 10⁻³ mm²/s, which was statistically higher than benign and malignant renal masses (P < 0.05). The ADC value of benign masses was statistically higher than that of all histological types of malignant masses (P < 0.05). Among three histological types of malignancies, clear cell carcinoma showed the statistically highest ADC value (P < 0.05). But the difference between papillary carcinoma and chromophobe carcinoma had no statistical significance (P > 0.05).Values of K(trans), Kep and Ve between normal renal parenchyma and different histological types of renal masses had statistical differences.Values of K(trans) and Ve in three histological types of malignant renal masses were statistically higher than those of benign renal masses.Kep value of clear cell carcinoma was significantly higher than that of benign renal masses (P < 0.05).However, other histological types of malignant masses had no significant difference with benign masses.For three malignant masses, K(trans) of clear cell carcinoma, papillary carcinoma and chromophobe carcinoma were (0.85 ± 0.27), (0.51 ± 0.04) and (0.39 ± 0.05)/min respectively. All values gradually reduced. And the differences were statistically significant (P < 0.05). The Ve value of renal clear cell carcinoma was statistically higher than that of papillary carcinoma (P < 0.05). ROC curve was used to analyze and compare the diagnostic value of PWI versus DWI in differentiating benign and malignant renal masses. The K(trans) of benign and malignant renal masses had the largest AUC (AUC = 0.937) at a threshold of 0.38/min. And there were a sensitivity of 87.9% and a specificity of 85.7%. The AUC of ADC was 0.823, sensitivity 72.7% and specificity 92.9%. The ADC threshold for differentiating benign from malignant masses was 1.40 × 10⁻³ mm²/s; AUC of Ve 0.803, sensitivity 78.8% and specificity 71.4%, a threshold of 0.29/min; Kep showed lower diagnostic value. CONCLUSION:3.0 T MRI DWI and PWI can effectively differentiate benign and different histological types of malignant renal masses. And PWI is superior to DWI in differentiating benign and malignant renal masses.K(trans) with the largest AUC showed the highest diagnostic value. And ADC is also irreplaceable in providing the information of cellular structural features and the movement of water diffusion.

Diffusion-weighted MRI in Bladder Carcinoma: the Differentiation Between Tumor Recurrence and Benign Changes after Resection

Application of Diffusion-Weighted Imaging in Following-Up of Bladder Tumor After Operation

The Role of Diffusion-Weighted MR Imaging in Diagnosis of Bladder Cancer

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

The differential diagnosis of malignant and benign bladder neoplasm using diffusion-weighted MR imaging

Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer.

Multiparametric 3-T MRI for Differentiating Low-Versus High-Grade and Category T1 Versus T2 Bladder Urothelial Carcinoma

Intravoxel Incoherent Motion Diffusion‐weighted Imaging in Assessing Bladder Cancer Invasiveness and Cell Proliferation

Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and Multidetector Computed Tomography

[Diffusion Weighted Imaging and Perfusion Weighted Imaging in the Differential Diagnosis of Benign and Malignant Renal Masses on 3.0 T MRI].

The role of diffusion-weighted MR imaging in the diagnosis of bladder urothelial cancer

Combined T2 SPAIR, Dynamic Enhancement and DW Imaging Reliably Detect T Staging and Grading of Bladder Cancer with 3.0T MRI

Evaluation of Isotropic High-Resolution IRIS Diffusion-Weighted MRI in Bladder Cancer: Clinical Experience

The Utility of Diffusion-Weighted Mr Imaging in Cervical Cancer

Comparison of Computed and Acquired DWI in the Assessment of Rectal Cancer: Image Quality and Preoperative Staging.

Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer

Preliminary study of diffusion-weighted MRI in the preoperative diagnosis of cystitis glandularis.

Comparison of Early Submucosal Enhancement and Tumor Stalk in Staging Bladder Urothelial Carcinoma.

Combining DWI Radiomics Features with Transurethral Resection Promotes the Differentiation Between Muscle-Invasive Bladder Cancer and Non-Muscle-invasive Bladder Cancer

Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.

Radiomics Assessment of Bladder Cancer Grade Using Texture Features from Diffusion-Weighted Imaging.